Karyopharm Therapeutics Inc.
What this means
- Bankruptcy or receivership reportedThe company reported a bankruptcy or receivership under Item 1.03 of Form 8-K on Nov 3, 2026. Creditors file claims with the bankruptcy court; the docket is on PACER.
- Debt accelerated or in defaultOn Nov 3, 2026 the company reported an event that accelerates or increases a direct financial obligation (Item 2.04), for example a default under a loan or bond agreement.
- Exchange listing at riskOn Nov 5, 2026 the company disclosed a notice from its exchange (Item 3.01). Exchanges usually give a period to regain compliance before delisting.
- Quarterly report lateOn Nov 13, 2026 the company filed Form NT 10-Q: it could not file its quarterly report on time. Rule 12b-25 gives an extra 15 calendar days for an annual report and 5 for a quarterly report. We have no later report from the company yet.
- Stockholders’ deficitAt the end of 2025 total liabilities exceeded total assets: stockholders’ equity was −$293M (XBRL data filed with the SEC).
- Net loss in 2025Net loss of $196M for the year (2024: −$76.4M).
What to do next
- NT 10-K: what a late-filing notice actually meansguide
- 8-K Item 1.03: what a bankruptcy filing means for suppliersguide
- How to check a US company before you sign a contractguide
Guides from the Companies Daily newsroom, picked for what the register shows.
Financials from XBRL
| Calendar-year frame | 2025 | 2024 |
|---|---|---|
| Revenue | $146M | $145M |
| Net income (loss) | −$196M | −$76.4M |
| Total assets | $108M | $164M |
| Total liabilities | $401M | $350M |
| Stockholders’ equity | −$293M | −$186M |
| Cash and equivalents | $60.5M | $62.5M |
From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.
- Name as filed
- Karyopharm Therapeutics Inc.
- CIK
- 0001503802
- Tickers
- KPTIQ, KPTI
- Kind of filer
- SEC-reporting company
Non-accelerated filer; Smaller reporting company - Status
- Bankruptcy reported
- State of incorporation
- Delaware
- Business address
- Newton, Massachusetts
- Industry (SIC)
- 2834 · Pharmaceutical preparations
Industry: D · Manufacturing → - Fiscal year ends
- December 31
- Last annual report
- 10-K for the period ended Dec 31, 2025
- Last quarterly report
- 10-Q for the quarter ended Jun 30, 2026
- Bankruptcy reported
- Yes (8-K Item 1.03)
- Last edition event
- Nov 13, 2026
Filing history
Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.
- Form NT 10-Q · filed Nov 13, 2026 · filing · edition of Nov 13, 2026
- Form 8-K · items 3.01 · filed Nov 5, 2026 · filing
- Form 8-K · items 1.01, 1.03, 2.03, 2.04, 7.01, 8.01, 9.01 · filed Nov 3, 2026 · filing · edition of Nov 3, 2026
- Form 8-K · items 1.01, 1.03, 2.03, 2.04, 7.01, 8.01, 9.01 · filed Nov 3, 2026 · filing · edition of Nov 3, 2026
- Form 8-K · items 1.01, 2.04, 3.02, 8.01, 9.01 · filed Sep 11, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 13, 2026 · filing
- Form 10-Q · filed Aug 13, 2026 · filing
- Form 8-K · items 5.02 · filed Jul 17, 2026 · filing
- Form 8-K · items 5.02, 5.07, 9.01 · filed May 28, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed May 14, 2026 · filing
- Form 10-Q · filed May 14, 2026 · filing
- Form 10-K · filed Feb 13, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Feb 12, 2026 · filing
- Form 8-K · items 2.02, 8.01, 9.01 · filed Jan 12, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 3, 2025 · filing
- Form 10-Q · filed Nov 3, 2025 · filing
- Form 8-K · items 1.01, 2.02, 2.03, 3.02, 5.02, 7.01, 8.01, 9.01 · filed Oct 8, 2025 · filing
- Form 8-K · items 1.01, 2.02, 2.03, 3.02, 5.02, 7.01, 8.01, 9.01 · filed Oct 8, 2025 · filing
- Form 8-K · items 5.02 · filed Sep 11, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 11, 2025 · filing
- Form 10-Q · filed Aug 11, 2025 · filing
- Form 8-K · items 5.02, 5.07, 9.01 · filed May 29, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed May 12, 2025 · filing
- Form 10-Q · filed May 12, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Feb 19, 2025 · filing
- Form 10-K · filed Feb 19, 2025 · filing
- Form 8-K · items 5.02 · filed Jan 31, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Jan 13, 2025 · filing
- Form 8-K · items 5.02, 9.01 · filed Jan 2, 2025 · filing
- Form 8-K · items 5.02 · filed Nov 20, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 5, 2024 · filing
- Form 10-Q · filed Nov 5, 2024 · filing
- Form 8-K · items 3.01 · filed Sep 17, 2024 · filing
- Form 8-K · items 5.02, 9.01 · filed Aug 29, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 6, 2024 · filing
- Form 10-Q · filed Aug 6, 2024 · filing
- Form 8-K · items 5.02, 5.07, 9.01 · filed May 31, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed May 8, 2024 · filing
- Form 10-Q · filed May 8, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Feb 29, 2024 · filing
- Form 10-K · filed Feb 29, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Jan 8, 2024 · filing
- Form 8-K · items 3.01 · filed Dec 12, 2023 · filing
- Form 8-K · items 5.02 · filed Dec 8, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 2, 2023 · filing
- Form 10-Q · filed Nov 2, 2023 · filing
- Form 8-K · items 5.02 · filed Sep 1, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 2, 2023 · filing
- Form 10-Q · filed Aug 2, 2023 · filing
- Form 8-K · items 5.02, 5.07, 9.01 · filed May 25, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed May 4, 2023 · filing
- Form 10-Q · filed May 4, 2023 · filing
- Form 10-K · filed Feb 17, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed Feb 15, 2023 · filing
- Form 8-K · items 5.02, 9.01 · filed Feb 15, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed Jan 9, 2023 · filing